Health & Fitness
Health and Fitness
Health and Fitness
Thu, October 13, 2011Wed, October 12, 2011Tue, October 11, 2011Mon, October 10, 2011Sun, October 9, 2011Sat, October 8, 2011Fri, October 7, 2011Thu, October 6, 2011Wed, October 5, 2011Tue, October 4, 2011Mon, October 3, 2011Sun, October 2, 2011Sat, October 1, 2011Fri, September 30, 2011Thu, September 29, 2011Wed, September 28, 2011Tue, September 27, 2011Mon, September 26, 2011Sat, September 24, 2011Fri, September 23, 2011Thu, September 22, 2011Wed, September 21, 2011Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
Published in Health and Fitness on Tuesday, October 4th 2011 at 17:41 GMT by Market Wire
WAYNE, Pa.--([ BUSINESS WIRE ])--Ryan & Maniskas, LLP ([ www.rmclasslaw.com/cases/ppdi ]) is investigating potential claims against the board of directors of Pharmaceutical Product Development Inc. ("PPD" or the "Company") (NASDAQ: PPDI) concerning possible breaches of fiduciary duty and other violations of law related to the Companya™s efforts to sell PPD to by an affiliate of The Carlyle Group and Hellman & Friedman in a transaction valued at approximately $3.9 billion.
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by Companya™s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of PPD. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at [ rmaniskas@rmclasslaw.com ] or visit: [ www.rmclasslaw.com/cases/ppdi ].
Under the terms of the definitive agreement, PPD shareholders will receive $33.25 in cash for each share of PPD common stock they own.
If you own shares of PPD and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: [ www.rmclasslaw.com/cases/ppdi ]. You may also email Mr. Maniskas at [ rmaniskas@rmclasslaw.com ]. For more information about class action cases in general, please visit our website: [ www.rmclasslaw.com ].
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
